The purpose of this clinical investigation is to assess the programming behavior of the physicians in the patient cohort. Furthermore, the acceptance level of specific programming recommendations based on the patient's clinical needs and primary indications will be evaluated by comparing parameters determined by the feature IBP to daily life programming chosen by physicians.

Inclusion Criteria:

• Implanted with a single or dual chamber ICD or CRT-D device approved in Japan capable of using the IBP feature.
• Geographically stable patients who are available for follow-up at a study center .
• Age 20 years or above.
• Patients, who do receive all leads that are supposed to be used with a certain type of device (i.e. no dual chamber ICD / CRT-D device without an atrial lead or CRT-D devices with only one ventricular lead).

Exclusion Criteria:

• Inability or refusal of the patient to give approval to collect/store/process personal health information at the sponsor.
• Pregnant women or women, planning to become pregnant .
• Any kind of previous CRM device therapy (no replacements, no upgrades, no new implants after complete system removals ).
• Enrolment in another clinical trial or clinical investigation without prior notification of the sponsor .
• Estimated life expectancy of less than six months per judgment of the physician.

The patient population comprises the standard patient population of the participating sites indicated for the intended devices per local guidelines in the study centers.